With so few chances for EAN staff and members to meet in person, we decided to introduce the team behind the scenes. This time it's Lucia, Head of the Memberhip and Scientific Departments, and Anja, from the Communications Department.

EAN Programme Committee Chair, Tony Marson, on abstract submission, registration and the preliminary programme for EAN 2022.

Our research paper of the month is a multicentre, randomised and double-blind phase 2 study with a futility design, exploring the efficacy and the safety of guanabenz in patients with probable or definite amyotrophic lateral sclerosis (ALS).

Our authors of the month conducted a systematic review of SARS-CoV-2-associated deaths in Hamburg, Germany, from March to December 2020, using conventional autopsy, ultrasound-guided minimally invasive autopsy, postmortem computed tomography (PMCT) and medical record review.

On 30 November the European Brain Council held an event to build on the latest discussions on the Declaration on Good Off-Label Use Practices.

The OneNeurology European Summit took place on 17 December 2021 under the patronage of the Slovenian Presidency in the Council of the EU

Read the latest reports on EAN clinical fellowships in Lille (FR) and Münster (DE)

Read the latest reports on EAN clinical fellowships in Paris (FR) and Erlangen (DE)

The European Academy of Neurology launched the first of its new National Neurological Society Forum meetings on Wednesday, December 15. Representatives from more than 40 societies which are EAN institutional members joined the meeting to get a glimpse of EAN’s progress in advocating for neurology and brain health on the European level.

The HBP and EBRAINS together with the European Academy of Neurology invited the entire scientific community to join a workshop on the Future of Medical Data Sharing in Clinical Neurosciences on 9–11 December 2021.

Did you miss any interesting EAN educational events last year? Check out all our webcasts from the virtual events!.

The editorial team of the European Journal of Neurology welcomes two new colleagues, starting in January 2022. Alessandro Tessitore and Barbara Borroni have both joined as Associate Editors.

This parallel-group, double- blind, ransomised, placebo-controlled trial conducted in 26 United Kingdom centres, investigated the efficacy and tolerability of mirtazapine versus placebo in treating agitation in patients with probable or possible Alzheimer’s disease.

This study investigated the potential benefits of smoking cessation in slowing down clinical progression in patients with multiple sclerosis.

Twenty patients hospitalized with COVID-19 encephalopathy were included in this retrospective cohort study.